KFH-Bahrain owns a 55% share in Al-Kindi Pharmaceutical Industries PLC, a specialized pharmaceutical company which serves as the nucleus for biotechnology development in Jordan and in the region. Al-Kindi is a specialized manufacturer and distributor of human-based Insulin, a range of intravenous solutions and Haemodialysis Solutions under license from major international pharmaceutical companies. It fully complies with European Union, FDA and Jordan Food and Drugs Association manufacturing standards. Al-Kindi was established in response to the demand for specialized and affordable locally manufactured drugs.
While nearing commercial production, Al-Kindi has been setting up expansion plans that will double production capacity and augment its product lines to meet the demands of a growing market in the MENA region. During 2006, Al-Kindi secured its first order to supply labelled insulin to Syria, Palestine and Iraq through a United Nations sponsored program.
For more information visit www.alkindipharma.com